Details of the Drug Reposition

General Information of This Drug (ID: DMB0CXT)

Drug Name	GSK2330811 DMB0CXT

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Systemic sclerosis	DISF44L6	4A42	Phase 2	[1]
Crohn disease	DIS2C5Q8	DD70	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT04151225) Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease (COSMIS). U.S. National Institutes of Health.